Barbarossa Alexia, Argentieri Maria Pia, Diella Maria Valeria, Caforio Anita, Carrieri Antonio, Corbo Filomena, Rosato Antonio, Carocci Alessia
Department of Pharmacy-Pharmaceutical Sciences, University of Bari "Aldo Moro", Via E. Orabona, 4, 70125 Bari, Italy.
Foods. 2025 Jul 24;14(15):2600. doi: 10.3390/foods14152600.
BACKGROUND/OBJECTIVES: The liver, the body's primary detoxifying organ, is often affected by various inflammatory diseases, including hepatitis, cirrhosis, and non-alcoholic fatty liver disease (NAFLD), many of which can be exacerbated by secondary infections such as spontaneous bacterial peritonitis, bacteremia, and sepsis-particularly in patients with advanced liver dysfunction. The global rise in these conditions underscores the need for effective interventions. Natural products have attracted attention for their potential to support liver health, particularly through synergistic combinations of plant extracts. , a dietary supplement from Erbenobili S.r.l., formulated with plant extracts like (L.), (L.) , and (L.), known for their liver-supporting properties, has been proposed as adjuvant for liver functions. The aim of this work was to evaluate of 's antioxidant, anti-inflammatory, and protective effects against heavy metal-induced toxicity. In addition, the antibacterial effect of against a panel of bacterial strains responsible for infections associated with liver injuries has been evaluated.
The protection against oxidative stress induced by HO was evaluated in HepG2 and BALB/3T3 cells using the dichlorofluorescein diacetate (DCFH-DA) assay. Its anti-inflammatory activity was investigated by measuring the reduction in nitric oxide (NO) production in LPS-stimulated RAW 264.7 macrophages using the Griess assay. Additionally, the cytoprotecting of against heavy metal-induced toxicity and oxidative stress were evaluated in HepG2 cells using the [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide] (MTT) and DCFH-DA assays. The antibacterial activity of was assessed by determining the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) against Gram-positive ( ATCC 29212, and BS, 25923, 29213, 43300, and BS) and Gram-negative ( 25922, and BS, 13883, 70063, and BS) bacterial strains using the microdilution method in broth, following the Clinical and Laboratory Standards Institute's (CLSI) guidelines.
effectively reduced oxidative stress in HepG2 and BALB/3T3 cells and decreased NO production in LPS-stimulated RAW 264.7 macrophages. Moreover, demonstrated a protective effect against heavy metal-induced toxicity and oxidative damage in HepG2 cells. Finally, it exhibited significant antibacterial activity against both Gram-positive and Gram-negative bacterial strains, with MIC values ranging from 1.5 to 6.0 mg/mL.
The interesting results obtained suggest that may serve as a valuable natural adjuvant for liver health by enhancing detoxification processes, reducing inflammation, and exerting antibacterial effects that could be beneficial in the context of liver-associated infections.
背景/目的:肝脏是人体主要的解毒器官,常受各种炎症性疾病影响,包括肝炎、肝硬化和非酒精性脂肪性肝病(NAFLD),其中许多疾病会因自发性细菌性腹膜炎、菌血症和败血症等继发感染而加重,尤其是在肝功能晚期患者中。这些疾病在全球范围内的增加凸显了有效干预措施的必要性。天然产物因其支持肝脏健康的潜力而受到关注,特别是通过植物提取物的协同组合。Erbenobili S.r.l.公司生产的一种膳食补充剂,由具有肝脏支持特性的植物提取物如(L.)、(L.)和(L.)配制而成,已被提议作为肝功能的辅助剂。这项工作的目的是评估其抗氧化、抗炎以及对重金属诱导毒性的保护作用。此外,还评估了其对一组与肝损伤相关感染的细菌菌株的抗菌作用。
使用二氯荧光素二乙酸酯(DCFH-DA)测定法在HepG2和BALB/3T3细胞中评估对HO诱导的氧化应激的保护作用。通过使用Griess测定法测量LPS刺激的RAW 264.7巨噬细胞中一氧化氮(NO)产生的减少来研究其抗炎活性。此外,使用[3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四氮唑](MTT)和DCFH-DA测定法在HepG2细胞中评估对重金属诱导的毒性和氧化应激的细胞保护作用。通过按照临床和实验室标准研究所(CLSI)的指南,使用肉汤微量稀释法测定对革兰氏阳性(ATCC 29212和BS、25923、29213、43300和BS)和革兰氏阴性(25922和BS、13883、70063和BS)细菌菌株的最低抑菌浓度(MIC)和最低杀菌浓度(MBC)来评估的抗菌活性。
有效降低了HepG2和BALB/3T3细胞中的氧化应激,并减少了LPS刺激的RAW 264.7巨噬细胞中NO的产生。此外,在HepG2细胞中表现出对重金属诱导的毒性和氧化损伤的保护作用。最后,它对革兰氏阳性和革兰氏阴性细菌菌株均表现出显著的抗菌活性,MIC值范围为1.5至6.0 mg/mL。
获得的有趣结果表明,可能通过增强解毒过程、减轻炎症以及发挥抗菌作用,成为肝脏健康有价值的天然辅助剂,这在与肝脏相关的感染情况下可能是有益的。